Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard I Shader

Showing results (1-10 of 187) with videos related to

Pageof 19
Sort By:
Journal of Clinical Psychopharmacology|May 15, 2002
Discontinue after last dose--an editorial and information about prescription writingRichard I Shader
Journal of Clinical Psychopharmacology|January 14, 2021
Acetaminophen (Paracetamol), COVID-19, and Misleading Conclusions: A CommentaryRichard I Shader
Clinical Therapeutics|May 5, 2020
COVID-19 and DepressionRichard I Shader
Clinical Therapeutics|May 4, 2015
Some Reflections on the Microbiome and ObesityRichard I Shader
Journal of Clinical Psychopharmacology|August 9, 2021
The Placenta and Psychiatry?Richard I Shader
Clinical Therapeutics|December 5, 2016
Some Thoughts on Pharmacovigilance and Postmarketing SurveillanceRichard I Shader
Journal of Clinical Psychopharmacology|February 23, 2017
In Memorium-Martin M. Katz, PhD (1927-2017)Richard I Shader
Clinical Therapeutics|September 2, 2019
Further Thoughts about Opioids and CannabinoidsRichard I Shader
Clinical Therapeutics|April 20, 2017
Vitamins C and DRichard I Shader
Journal of Clinical Psychopharmacology|October 31, 2022
Statistical Versus Clinical Significance: A Question About Caplyta (Lumateperone)Richard I Shader
Pageof 19

Showing results (1-10 of 187) with videos related to

Sort By:
Pageof 19
Journal of Clinical Psychopharmacology|May 15, 2002
Discontinue after last dose--an editorial and information about prescription writingRichard I Shader
Journal of Clinical Psychopharmacology|January 14, 2021
Acetaminophen (Paracetamol), COVID-19, and Misleading Conclusions: A CommentaryRichard I Shader
Clinical Therapeutics|May 5, 2020
COVID-19 and DepressionRichard I Shader
Clinical Therapeutics|May 4, 2015
Some Reflections on the Microbiome and ObesityRichard I Shader
Journal of Clinical Psychopharmacology|August 9, 2021
The Placenta and Psychiatry?Richard I Shader
Clinical Therapeutics|December 5, 2016
Some Thoughts on Pharmacovigilance and Postmarketing SurveillanceRichard I Shader
Journal of Clinical Psychopharmacology|February 23, 2017
In Memorium-Martin M. Katz, PhD (1927-2017)Richard I Shader
Clinical Therapeutics|September 2, 2019
Further Thoughts about Opioids and CannabinoidsRichard I Shader
Clinical Therapeutics|April 20, 2017
Vitamins C and DRichard I Shader
Journal of Clinical Psychopharmacology|October 31, 2022
Statistical Versus Clinical Significance: A Question About Caplyta (Lumateperone)Richard I Shader
Pageof 19